Mimedx (MDXG) Enterprise Value Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Mimedx | 530.69 Mn | 370.92 Mn | 41.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -50.12% |
| Dec 31, 2025 | -59.10% |
| Sep 30, 2025 | -60.00% |
| Jun 30, 2025 | -72.18% |
| Mar 31, 2025 | -119.50% |
| Dec 31, 2024 | -27.34% |
| Jun 30, 2024 | -0.56% |
| Mar 31, 2024 | 20.80% |
| Dec 31, 2023 | -24.34% |
| Jun 30, 2023 | 5.31% |
| Mar 31, 2023 | 19.10% |
| Dec 31, 2022 | 24.27% |
| Sep 30, 2022 | 19.19% |
| Jun 30, 2022 | 14.71% |
| Mar 31, 2022 | 10.70% |
| Dec 31, 2021 | 9.11% |
| Sep 30, 2021 | 17.33% |
| Jun 30, 2021 | -76.36% |
| Mar 31, 2021 | -58.40% |
| Dec 31, 2020 | -38.72% |
| Sep 30, 2020 | -16.44% |
| Jun 30, 2020 | 50.26% |
| Mar 31, 2020 | -88.51% |
| Dec 31, 2019 | -53.09% |
| Dec 31, 2018 | -64.21% |
| Dec 31, 2017 | 9.38% |
| Sep 30, 2017 | -99.16% |
| Jun 30, 2017 | -99.69% |
| Mar 31, 2017 | -75.53% |
| Dec 31, 2016 | -3.48% |
| Sep 30, 2016 | 61.45% |
| Jun 30, 2016 | 48.09% |
| Mar 31, 2016 | 60.58% |
| Dec 31, 2015 | 44.01% |
| Sep 30, 2015 | -0.68% |
| Jun 30, 2015 | -16.83% |
| Mar 31, 2015 | -3.90% |
| Dec 31, 2014 | -18.73% |
| Sep 30, 2014 | -679.51% |
| Jun 30, 2014 | -835.83% |
| Mar 31, 2014 | -651.41% |
| Dec 31, 2013 | -552.62% |
| Sep 30, 2013 | 20.46% |
| Jun 30, 2013 | -57.97% |
| Mar 31, 2013 | -89.49% |
| Dec 31, 2012 | -64.21% |
| Sep 30, 2012 | -1,096.06% |
| Jun 30, 2012 | -64.44% |
| Mar 31, 2012 | -196.05% |
| Dec 31, 2011 | -206.73% |